Aortic stenosis future or investigational therapies
|
Aortic Stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty |
|
Transcatheter Aortic Valve Replacement (TAVR) |
|
Case Studies |
|
Aortic stenosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Aortic stenosis future or investigational therapies |
|
Aortic stenosis future or investigational therapies in the news |
|
Blogs on Aortic stenosis future or investigational therapies |
|
Directions to Hospitals Treating Aortic stenosis future or investigational therapies |
|
Risk calculators and risk factors for Aortic stenosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Transcatheter aortic valve implantation (TAVI) is more cost-effective compared to medical management among aortic stenosis patients unsuitable for surgery. Among patients suitable for surgery, surgical aortic valve replacement is more cost-effective than TAVI.[1]
References
- ↑ Orlando R, Pennant M, Rooney S, Khogali S, Bayliss S, Hassan A; et al. (2013). "Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation". Health Technol Assess. 17 (33): 1–86. doi:10.3310/hta17330. PMID 23948359.